statistiche ricercatore

Continente	#
NA - Nord America	1.534
EU - Europa	634
AS - Asia	502
SA - Sud America	79
AF - Africa	13
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.763

Nazione	#
US - Stati Uniti d'America	1.513
SG - Singapore	201
RU - Federazione Russa	173
IT - Italia	149
CN - Cina	142
DE - Germania	81
BR - Brasile	59
FI - Finlandia	50
GB - Regno Unito	38
HK - Hong Kong	37
VN - Vietnam	37
FR - Francia	32
PL - Polonia	28
IE - Irlanda	21
IN - India	21
JP - Giappone	18
CA - Canada	16
BE - Belgio	15
KR - Corea	12
AR - Argentina	11
ES - Italia	8
SE - Svezia	8
UA - Ucraina	8
IQ - Iraq	7
NL - Olanda	7
TR - Turchia	7
BD - Bangladesh	5
ZA - Sudafrica	4
CH - Svizzera	3
CI - Costa d'Avorio	3
EC - Ecuador	3
PK - Pakistan	3
PY - Paraguay	3
RO - Romania	3
VE - Venezuela	3
HU - Ungheria	2
ID - Indonesia	2
IL - Israele	2
LT - Lituania	2
MA - Marocco	2
TN - Tunisia	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BG - Bulgaria	1
BY - Bielorussia	1
CR - Costa Rica	1
DZ - Algeria	1
EE - Estonia	1
EU - Europa	1
GD - Grenada	1
GT - Guatemala	1
JO - Giordania	1
KE - Kenya	1
MX - Messico	1
OM - Oman	1
PH - Filippine	1
PT - Portogallo	1
QA - Qatar	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	2.763

Nome	#
Dietary restriction: could it be considered as speed bump on tumor progression road?	322
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines	316
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?	310
A headlight on liquid biopsies: a challenging tool for breast cancer management	280
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway	261
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer	261
Liquid Biopsy in Breast Cancer	248
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions	246
Targeting PAM signaling pathway in the treatment of pancreatic ductal adenocarcinoma	181
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines	165
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma	153
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis	99
Totale	2.842

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	51	0	0	0	0	0	0	0	0	0	0	33	18
2021/2022	182	14	38	7	8	6	14	13	11	15	22	11	23
2022/2023	220	24	36	4	35	24	28	16	17	28	0	7	1
2023/2024	113	7	12	4	14	6	27	13	9	0	1	0	20
2024/2025	247	3	11	7	26	12	7	18	33	13	36	30	51
2025/2026	913	81	31	41	90	131	151	127	92	78	65	26	0
Totale													2.842

Archivio istituzionale della ricerca dell'Università degli Studi di Palermo